Capella Education Co (CPLA) 53.49 $CPLA DeVry Education

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 6:09 PM

Capella Education Co (CPLA) 53.49 $CPLA

DeVry Education (DV) Subsidiary Closes ACAMS Acquisition
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:54AM CDT
DeVry's subsidiary, Becker Professional Education closed its acquisition of the Association of Certified Anti-Money Laundering Specialists (ACAMS) for $330 million.
APEI: 28.63 (+0.83), CPLA: 53.49 (+0.79), DV: 19.97 (+0.62), APOL: 9.05 (+0.01)

Hanesbrands (HBI) CEO Steps Down, Will Act as Chairman
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 5:02PM CDT
Hanesbrands Inc.'s (HBI) shares tumbled almost 3% as its Chief Executive Officer (CEO) Richard A. Noll has decided to step down from his current role to focus on his role as the executive Chairman of the company.
DLA: 22.50 (+0.90), PERY: 20.47 (+0.04), HBI: 26.27 (+0.76), CPLA: 53.49 (+0.79)

Will Capella Sales Benefit from Non-Degree Programs in 2016?
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:48AM CDT
On Jun 13, 2016, we issued an updated research report on Capella Education Company (CPLA).
APEI: 28.63 (+0.83), ESI: 1.97 (+0.06), CPLA: 53.49 (+0.79), LINC: 1.47 (-0.06)

Apollo Education to Offer Online Program for New Managers
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 10:18AM CDT
Apollo Education Group, Inc. (APOL) recently partnered with The Center for Creative Leadership to introduce an online program called Frontline Leader Impact.
APEI: 28.63 (+0.83), EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79), APOL: 9.05 (+0.01)

ITT Educational Down to 52-Week Low, Freezes Tuition
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:11AM CDT
Shares of ITT Educational Services, Inc. (ESI) dropped to a new 52-week low of $1.90 on Jun 7.
APEI: 28.63 (+0.83), ESI: 1.97 (+0.06), CPLA: 53.49 (+0.79), LINC: 1.47 (-0.06)

Pilgrim's Receives State Approval for Expansion Project
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 8:57AM CDT
Pilgrim's Pride Corporation (PPC) has gained a state approval for an expansion project at its Mayfield, KY-based poultry processing complex.
PPC: 25.79 (-0.03), CPLA: 53.49 (+0.79), CRI: 108.20 (+0.62), TSN: 68.92 (+1.26)

Can Mohawk Industries Gain from Housing Recovery in 2016?
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 7:25AM CDT
On Jun 3, 2016, we issued an updated research report on Mohawk Industries, Inc. (MHK).
APEI: 28.63 (+0.83), MHK: 194.20 (+5.00), LEG: 52.03 (+0.88), CPLA: 53.49 (+0.79)

Apollo Education Unit to Open RedFlint Innovation Center
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 9:48AM CDT
Apollo Education Group, Inc.???s (APOL), University of Phoenix???s College of Information Systems & Technology and School of Business collaborated with Iron Yard Ventures.
APEI: 28.63 (+0.83), EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79), APOL: 9.05 (+0.01)

iRobot's Business Initiatives Impress, Forex Risks a Drag
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:59AM CDT
We issued an updated research report on premium appliances company iRobot Corporation (IRBT) on May 30, 2016.
AMCX: 59.35 (+0.58), CPLA: 53.49 (+0.79), CRI: 108.20 (+0.62), IRBT: 35.39 (+0.49)

American Public (APEI) Up to Strong Buy on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed May 11, 9:19AM CDT
American Public Education, Inc (APEI) was upgraded to a Zacks Rank #1 (Strong Buy) on May 11 on strong first-quarter 2016 results.
APEI: 28.63 (+0.83), EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79), LINC: 1.47 (-0.06)

Consumer Stocks' Earnings Preview: ACAT, PRTY, PBH, VSTO
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:49AM CDT
The Q1 Earnings season is drawing to a close with almost 87% of the S&P 500 members having released their quarterly numbers so far.
RAI: 53.13 (+0.16), ACAT: 17.42 (+0.62), PBH: 55.83 (+0.59), PRTY: 14.36 (+0.15), THS: 104.17 (+1.52), SAM: 171.13 (+2.60), DV: 19.97 (+0.62), TSN: 68.92 (+1.26), K: 82.64 (+0.37), HOT: 76.70 (+1.16), APEI: 28.63 (+0.83), PM: 103.09 (+1.31), PPC: 25.79 (-0.03), CPLA: 53.49 (+0.79), EL: 93.01 (+1.46)

American Public (APEI) Beats Q1 Earnings & Sale Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:54AM CDT
American Public Education, Inc.'s (APEI) first-quarter 2016 adjusted earnings of 64 cents per share surpassed the Zacks Consensus Estimate of 45 cents by 42.2%.
APEI: 28.63 (+0.83), EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79), LINC: 1.47 (-0.06)

Apollo's (APOL) Majority Shareholders Vote for Going Private
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:59AM CDT
The recent shareholder's approval for the proposed divestiture of Apollo Education Group, Inc. (APOL) seems to have brought some respite for the company.
CPLA: 53.49 (+0.79), DV: 19.97 (+0.62), APOL: 9.05 (+0.01), LINC: 1.47 (-0.06)

DeVry Education (DV) Beats on Q3 Earnings and Revenues
Zacks Equity Research - Zacks Investment Research - Fri May 06, 4:04PM CDT
DeVry Education Group Inc. (DV) reported robust third-quarter fiscal 2016 results, surpassing the Zacks Consensus Estimate for both sales and earnings.
EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79), DV: 19.97 (+0.62), LINC: 1.47 (-0.06)

Consumer Stocks Q1 Earnings to Watch Next Week: TSN, DIS, EA
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:28AM CDT
Almost 75% of the total S&P 500 members have already reported earnings for the first quarter.
RAI: 53.13 (+0.16), KO: 45.38 (+0.29), PM: 103.09 (+1.31), EA: 78.26 (+1.64), COLM: 59.47 (+1.71), PPC: 25.79 (-0.03), SAM: 171.13 (+2.60), DIS: 99.62 (+1.21), HBI: 26.27 (+0.76), CPLA: 53.49 (+0.79), MO: 69.83 (+0.53), TSN: 68.92 (+1.26), EL: 93.01 (+1.46)

Capella Education Has Returned 17.7% Since SmarTrend Recommendation (CPLA)
Comtex SmarTrend(R) - Fri May 06, 1:18AM CDT
SmarTrend identified an Uptrend for Capella Education (NASDAQ:CPLA) on February 3rd, 2016 at $45.27. In approximately 3 months, Capella Education has returned 17.68% as of today's recent price of $53.27.
CPLA: 53.49 (+0.79)

Strayer Education (STRA) Q1 Earnings Beat, Starts Fall Y/Y
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:54AM CDT
Shares of Strayer Education, Inc. (STRA) declined 7.45% on May 4, after the education company???s sales fell short of market expectations.
BPI: 7.51 (+0.27), STRA: 49.74 (+1.20), EDU: 41.70 (+0.09), CPLA: 53.49 (+0.79)

Capella Acquisition of DevMountain Extends Leadership Position in Job-Ready Skills Market
BusinessWire - Wed May 04, 3:10PM CDT
Capella Education Company (NASDAQ: CPLA) today announced that DevMountain, an industry-leading coding school, has become a wholly-owned subsidiary of Capella Education Company. DevMountain's mission is to be the most accessible and impactful software coding school in the country by bringing affordability to the highest quality, hands-on education in the software coding industry. Following Capella's recent partnership with CareerBuilder(R) called RightSkill(SM) and acquisition of Hackbright Academy, DevMountain represents a complementary platform on which to extend Capella's leadership position in the job-ready skills market.
CPLA: 53.49 (+0.79)

Education Earnings Lined Up for the Next Few Days: DV, APEI
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:34AM CDT
Two more companies from the education sector, DeVry Education Group Inc. (DV) and American Public Education, Inc. (APEI) are set to report their quarterly results soon.
APEI: 28.63 (+0.83), ESI: 1.97 (+0.06), CPLA: 53.49 (+0.79), DV: 19.97 (+0.62), APOL: 9.05 (+0.01), XRS: 61.96 (-0.04)

Capella Education Company Announces Quarterly Cash Dividend
BusinessWire - Tue May 03, 3:30PM CDT
Capella Education Company (NASDAQ:CPLA), a leading education provider, announced today that its board of directors has approved a quarterly cash dividend of $0.39 per outstanding share of common stock. The cash dividend is payable on July 15, 2016 to shareholders of record as of the close of business on May 25, 2016.
CPLA: 53.49 (+0.79)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Millrose Faces Securities Fraud Suit Amidst Decline

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 134

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...